MDxHealth director granted 10,000 options at $0.76

MDxHealth SA director Don M. Hardison received a grant of share options as part of his compensation.

Rhea-AI Filing Summary

MDxHealth SA director Don M. Hardison received a grant of share options as part of his compensation. The award covers 10,000 options to purchase ordinary shares at an exercise price of $0.76 per share, granted on June 1, 2026.

The options vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year after the year of grant and expire on May 28, 2036. Following this grant, Hardison holds 10,000 share options directly.

Insights

Equity compensation analyst

Director receives routine option grant, adding 10,000 options at a $0.76 exercise price.

Director Don M. Hardison was granted 10,000 share options for MDxHealth SA ordinary shares at an exercise price of $0.76, expiring on May 28, 2036. This is compensation-related and not an open-market trade.

The options vest in full at the annual general shareholders' meeting held in the calendar year after the grant year, tying his upside to future company performance. After this grant he holds 10,000 options directly, indicating a relatively small but aligned equity incentive.

Insider Trade Summary

Grant/Award: 10,000 shares

Grant/Award 1 txn

Insider HARDISON DON M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option	10,000	$0.00	$0.00

Holdings After Transaction: Share Option — 10,000 contracts (Direct)

Footnotes (1)

1. F1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

Key Figures

Option grant size: 10,000 options Exercise price: $0.76 per share Underlying shares: 10,000 ordinary shares +3 more

6 metrics

Option grant size 10,000 options Share options granted to Don M. Hardison

Exercise price $0.76 per share Exercise price for MDxHealth ordinary shares

Underlying shares 10,000 ordinary shares Shares covered by the option grant

Expiration date May 28, 2036 Option expiration for Hardison’s grant

Post-transaction options held 10,000 options Total share options held following grant

Grant date June 1, 2026 Date the options were granted

Key Terms

Share Option, Ordinary Shares, annual general shareholders' meeting, exercise price

4 terms

Share Option financial

"Represents options to purchase 10,000 ordinary shares of the Issuer"

Ordinary Shares financial

"Represents options to purchase 10,000 ordinary shares of the Issuer"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

annual general shareholders' meeting financial

"vest in full on the date of the annual general shareholders' meeting"

A yearly meeting where a company’s shareholders and board of directors come together to review performance, vote on key issues (such as electing directors and approving auditors), and ask questions of management. Think of it like a town-hall or annual check-in where owners can influence how the company is run; outcomes can affect governance, dividend decisions and long-term strategy, all of which can influence the value and risks of an investor’s holdings.

exercise price financial

"at a price per share of $0.76 granted on June 1, 2026"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MDxHealth (MDXH) report for Don M. Hardison?

MDxHealth reported that director Don M. Hardison received 10,000 share options as compensation. These options give him the right to buy 10,000 ordinary shares at a fixed exercise price of $0.76 per share, subject to vesting and expiration terms described in the filing.

What are the key terms of Don M. Hardison’s MDXH option grant?

Hardison’s grant covers 10,000 options on MDxHealth ordinary shares at an exercise price of $0.76. The options were granted on June 1, 2026 and expire on May 28, 2036, providing a long-term incentive window for potential share acquisition if conditions are met.

When do Don M. Hardison’s MDxHealth (MDXH) options vest?

The 10,000 options granted to Hardison vest in full on the date of MDxHealth’s annual general shareholders' meeting held in the calendar year following the year of grant. This single vesting event aligns his equity award with a future shareholder meeting milestone.

How many MDxHealth share options does Don M. Hardison hold after this Form 4?

Following this transaction, Hardison holds 10,000 MDxHealth share options directly. Each option corresponds to one ordinary share, giving him potential future rights over 10,000 shares if he chooses to exercise at the stated $0.76 price after vesting.

Is Don M. Hardison’s MDXH Form 4 transaction a market purchase or sale?

The Form 4 reflects a grant of 10,000 share options as compensation, not a market purchase or sale. The transaction is coded as an acquisition (grant/award), meaning he received options rather than buying or selling shares on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HARDISON DON M

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL BELGIUM 4040

(City) (State) (Zip)

BELGIUM

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$0.76	06/01/2026		A		10,000		(1)	05/28/2036	Ordinary Shares	10,000	$0	10,000	D

Explanation of Responses:

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

	/s/ Mark Busch, as attorney-in-fact for Don M. Hardison	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)